Integra LifeSciences’ Registered Offering of 6,037,500 Shares of Common Stock


Simpson Thacher represented J.P. Morgan Securities LLC and Wells Fargo Securities, LLC as underwriters in connection with a registered offering of 6,037,500 shares of common stock (including full exercise of the underwriters’ option to purchase additional shares) of Integra LifeSciences Holdings Corporation (“Integra”) (NASDAQ: IART).

A total of approximately $350.2 million in proceeds before expenses was raised in the offering.

Integra is a worldwide leader in medical technology, focusing on cranial procedures, small bone and joint reconstructions, the repair and reconstruction of soft tissue and instruments for surgery.

The Simpson Thacher team included Art Robinson (Picture), Jonathan Ozner, Davis Mahon and Robert Meyer (Capital Markets); Michael Isby (Environmental); Andrew Blau and Joo Hyun Lee (Executive Compensation and Employee Benefits); Andrew Pagliughi (FINRA); Lori Lesser and Amber Harezlak (Intellectual Property); Noah Leibowitz (Healthcare); and Robert Holo and Dmitry Zelik (Tax).

Involved fees earner: Arthur Robinson – Simpson Thacher & Bartlett; Jonathan Ozner – Simpson Thacher & Bartlett; Davis Mahon – Simpson Thacher & Bartlett; Robert Meyer – Simpson Thacher & Bartlett; Michael Isby – Simpson Thacher & Bartlett; Andrew Blau – Simpson Thacher & Bartlett; Joo Hyun Lee – Simpson Thacher & Bartlett; Andrew Pagliughi – Simpson Thacher & Bartlett; Lori Lesser – Simpson Thacher & Bartlett; Amber Harezlak – Simpson Thacher & Bartlett; Noah Leibowitz – Simpson Thacher & Bartlett; Robert Holo – Simpson Thacher & Bartlett; Dmitry Zelik – Simpson Thacher & Bartlett;

Law Firms: Simpson Thacher & Bartlett;

Clients: JP Morgan Securities; Wells Fargo Securities;

Author: Ambrogio Visconti